Ann: Trading Halt, page-2

Market Announcement 12 October 2022

Botanix Pharmaceuticals Ltd (ASX: BOT) – Trading Halt

Description

The securities of Botanix Pharmaceuticals Ltd (‘BOT’) will be placed in trading halt at the request of BOT, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Friday, 14 October 2022 or when the announcement is released to the market.

Issued by

Damian Dinelli

Adviser, Listings Compliance (Perth)

12 October 2022

ASX Limited

Market Announcement 1/1

ASX Customer Service Centre 131 279 | asx.com.au

12 October 2022

The Manager
Australian Securities Exchange 152-158 St Georges Terrace PERTH WA 6000

[email protected]

Via email

Dear Sir,

REQUEST FOR A TRADING HALT

Pursuant to ASX Listing Rule 17.1, Botanix Pharmaceuticals Limited (ASX:BOT) (Company) requests a trading halt of its shares from ASX with immediate effect.

In accordance with ASX Listing Rule 17.1, the Company provides the following information regarding this request:

1. The reason for the trading halt is in order that the Company can make an announcement in relation to clinical study results.

2. The Company requests that the trading halt continue until the earlier of commencement of trading on Friday 14 October 2022 or when the announcement referred to in paragraph 1 is released to the market.

3. The Company expects the event which will end the trading halt is the announcement referred to in paragraph 1.

The Company is not aware of any reason why the trading halt should not be granted or of any other information necessary to inform the market about the trading halt.

Yours sincerely

Simon Robertson Company Secretary

Botanix Pharmaceuticals LimitedACN 009 109 755D2 661 Newcastle Street Leederville WA 6007